Discordant Results with Pimecrolimus 1% Cream in the Treatment of Plasma Cell Balanitis

Publisher： Karger

E-ISSN： 1421-9832|218|2|155-158

ISSN： 1018-8665

Source： Dermatology, Vol.218, Iss.2, 2008-10, pp. : 155-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pimecrolimus 1% Cream in Non-Specific Inflammatory Recurrent Balanitis

By  

Dermatology, Vol. 215, Iss. 3, 2007-09 ,pp. : 209-212

Karger

Access to resources Recommend Favorite

Occlusive Treatment of Chronic Hand Dermatitis with Pimecrolimus Cream 1% Results in Low Systemic Exposure, Is Well Tolerated, Safe, and Effective

By  

Dermatology, Vol. 207, Iss. 1, 2003-07 ,pp. : 37-42

Karger

Access to resources Recommend Favorite

Pimecrolimus 1% Cream in the Treatment of Facial Psoriasis: A 16-Week Open-Label Study

By  

Dermatology, Vol. 216, Iss. 2, 2008-01 ,pp. : 133-136

Karger

Access to resources Recommend Favorite

Rosaceiform Dermatitis with Follicular Demodex after Treatment of Facial Atopic Dermatitis with 1% Pimecrolimus Cream

By  

Dermatology, Vol. 207, Iss. 2, 2003-08 ,pp. : 205-207

Karger

Access to resources Recommend Favorite

Pimecrolimus Cream 1% for the Treatment of Papulopustular Eruption Related to Epidermal Growth Factor Receptor Inhibitors: A Case Series and a Literature Review of Therapeutic Approaches

By  

Dermatology, Vol. 220, Iss. 3, 2010-01 ,pp. : 243-248

Karger

Access to resources Recommend Favorite